Log In
BCIQ
Print this Print this
 

NKTR-192

  Manage Alerts
Collapse Summary General Information
Company Nektar Therapeutics
DescriptionOral mu opioid receptor (OPRM1; MOR) agonist
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat acute pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today